insider24.ch
Back to the feed

Shareholding disclosure

Santhera Pharmaceuticals Holding AG

inSanthera Pharmaceuticals Holding AG

Collectively declared rate

9.53%

Threshold

Crossed upwards

Timeline

Published

06.04.2016

Transaction

30.03.2016

Voting rights breakdown

Voting rights acquired9.53%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 3

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBG4400018

Beneficial owner

Mitchell Blutt

Declared address

Mitchell Blutt, New York

On 1 Jan 2016, the Swiss Financial Market Infrastructure Act (FMIA) with its respective ordinances (FMIO and FMIO-FINMA) entered into force. This filing replaces the previous filings of 23 and 24 Feb 2016, made under the transitional provisions of the FMIA, which were triggered by a sale of securities reducing holdings below 10% of the Company's voting shares on 22 Feb 2016.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open